1. Home
  2. GHRS vs ADSE Comparison

GHRS vs ADSE Comparison

Compare GHRS & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • ADSE
  • Stock Information
  • Founded
  • GHRS 2018
  • ADSE 1980
  • Country
  • GHRS Ireland
  • ADSE Ireland
  • Employees
  • GHRS N/A
  • ADSE N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • ADSE Industrial Specialties
  • Sector
  • GHRS Health Care
  • ADSE Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • ADSE Nasdaq
  • Market Cap
  • GHRS 753.0M
  • ADSE 647.1M
  • IPO Year
  • GHRS 2021
  • ADSE N/A
  • Fundamental
  • Price
  • GHRS $13.08
  • ADSE $12.05
  • Analyst Decision
  • GHRS Strong Buy
  • ADSE
  • Analyst Count
  • GHRS 8
  • ADSE 0
  • Target Price
  • GHRS $30.63
  • ADSE N/A
  • AVG Volume (30 Days)
  • GHRS 254.5K
  • ADSE 71.9K
  • Earning Date
  • GHRS 08-07-2025
  • ADSE 09-11-2025
  • Dividend Yield
  • GHRS N/A
  • ADSE N/A
  • EPS Growth
  • GHRS N/A
  • ADSE N/A
  • EPS
  • GHRS N/A
  • ADSE N/A
  • Revenue
  • GHRS N/A
  • ADSE $113,896,884.00
  • Revenue This Year
  • GHRS N/A
  • ADSE $219.58
  • Revenue Next Year
  • GHRS N/A
  • ADSE N/A
  • P/E Ratio
  • GHRS N/A
  • ADSE N/A
  • Revenue Growth
  • GHRS N/A
  • ADSE 2.45
  • 52 Week Low
  • GHRS $6.00
  • ADSE $9.00
  • 52 Week High
  • GHRS $20.50
  • ADSE $16.35
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 47.54
  • ADSE 54.85
  • Support Level
  • GHRS $11.32
  • ADSE $10.78
  • Resistance Level
  • GHRS $13.15
  • ADSE $12.47
  • Average True Range (ATR)
  • GHRS 0.73
  • ADSE 0.82
  • MACD
  • GHRS 0.05
  • ADSE 0.07
  • Stochastic Oscillator
  • GHRS 77.19
  • ADSE 78.01

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About ADSE ADS-TEC ENERGY PLC

ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: